Literature DB >> 31298350

Observation of curative effect of recombinant human basic fibroblast growth factor combined with compound polymyxin B ointment and local application of insulin on wound healing of deep second-degree burn in diabetes mellitus: a randomized study.

J-B Zhang1, H Li, L Zhang, J-L Wang.   

Abstract

OBJECTIVE: We aimed at investigating the clinical efficacy of recombinant human basic fibroblast growth factor combined with compound polymyxin B ointment and the local application of insulin on wound healing of deep second-degree burn in diabetes mellitus. PATIENTS AND METHODS: 80 diabetes mellitus patients complicated with deep second-degree burn treated from 2016 to December 2017 were selected and divided into observation group (n=40) and control group (n=40) using the random number method. Patients in control group were treated with compound polymyxin B ointment, while those in observation group were treated with basic fibroblast growth factor based on the treatment in control group. The time of wound pain relief, wound scarring, and wound healing was compared.
RESULTS: The number of positive bacteria in the wound was recorded and the duration of infection was also recorded. Moreover, the changes in the expressions of Advanced Glycation End products (AGEs) and Vascular Endothelial Growth Factor (VEGF) were analyzed. In observation group, the time of wound pain relief, wound scarring, and wound healing was significantly shorter than that in control group (p<0.05). At 3, 14, and 28 days after the treatment, the levels of AGEs in observation group were lower than those in control group, while the levels of VEGF in the observation group were higher than those in control group (p<0.05). The proportions of wound infection, skin necrosis, systemic blood infection, hypoglycemia, and hyperglycemia and the ineffective rate in observation group were significantly lower than that in control group (p<0.05).
CONCLUSIONS: The application of compound polymyxin B ointment and the local application of insulin combined with recombinant human basic fibroblast growth factor in diabetes mellitus patients complicated with a deep second-degree burn can effectively alleviate the pain, reduce the wound infection rate, promote the wound healing, and improve the overall therapeutic effect.

Entities:  

Year:  2019        PMID: 31298350     DOI: 10.26355/eurrev_201907_18345

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  3 in total

1.  Nanosilver Dressing in Treating Deep II Degree Burn Wound Infection in Patients with Clinical Studies.

Authors:  Bin'e Wu; Fengchun Zhang; Wenbin Jiang; Aiyan Zhao
Journal:  Comput Math Methods Med       Date:  2021-12-13       Impact factor: 2.238

2.  Glucose and MMP-9 dual-responsive hydrogel with temperature sensitive self-adaptive shape and controlled drug release accelerates diabetic wound healing.

Authors:  Wanyi Zhou; Zhiguang Duan; Jing Zhao; Rongzhan Fu; Chenhui Zhu; Daidi Fan
Journal:  Bioact Mater       Date:  2022-01-19

Review 3.  Topical Biological Agents as Adjuncts to Improve Wound Healing in Chronic Diabetic Wounds: A Systematic Review of Clinical Evidence and Future Directions.

Authors:  Andrew Yew Wei Wong; Bernard Soon Yang Ong; Ainsley Ryan Yan Bin Lee; Aaron Shengting Mai; Sathiyamoorthy Selvarajan; Satish R Lakshminarasappa; Sook Muay Tay
Journal:  Cureus       Date:  2022-07-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.